AstraZeneca AZN will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus ...

Flagship Harbor Advisors LLC lowered its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.5% during the 4th ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Diversify Wealth Management LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% during the ...

Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA approvals. Calquence, in combination with chemotherapy bendamustine and ...

The pact with Mankind Pharma, announced in March 2024, was an exclusive agreement for distribution of budesonide and formoterol fumarate dihydrate drug under the brand name of Symbicort, which is a ...

Jan 17 (Reuters) - AstraZeneca (AZN.L), opens new tab has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general manager, the Financial Times ...

When we think of artificial intelligence (AI), data science and the potential real-world impact of these rapidly developing fields, we tend to look to the future—particularly when it comes to ...

This group also includes SMART drugs like Symbicort (budesonide and formoterol fumarate dihydrate). Long-acting bronchodilators should not be used for an acute asthma attack or severe difficulty with ...

AstraZeneca PLC (NASDAQ ... their respiratory drug Symbicort posted impressive 21% growth, complemented by Ultomiris’s 7% gain. The company is now making a significant push into the American ...